Integrated discovery Concept Life Sciences offers end-to-end drug discovery and development services across five UK sites, presenting a ready-made partner for biotech and pharma companies seeking a seamless transition from discovery to GMP manufacturing.

OpenBench synergy Recent integrations with OpenBench AI-based discovery platforms signal opportunities to co-develop AI-enabled, structure-guided screening programs and leverage Concept Life Sciences' medicinal chemistry and in vitro validation capabilities.

Expanded facilities The 2026 expansion to UK, Northern Europe and Europe enhances capacity for assay development, screening, ADMET and GMP activities, enabling faster program progression and potential collaboration on larger, multi-region programs.

Regulated expertise With capabilities spanning discovery chemistry, immunology, neuroscience, analytical services and GMP manufacturing, Concept Life Sciences is positioned to support partners seeking regulated, end-to-end CRO/CMO solutions.

Industry engagement Active participation in major events (ACS Symposium, JPM Healthcare Conference) and leadership appointments (Chief Scientific Officer) indicate a growth-focused strategy and opportunities to engage decision-makers and secure strategic partnerships.